Jingyan Xu
-
- Lymphoma Diagnosis and Treatment 24
- Hematology top 10%
- Multiple Myeloma Research and Treatments 6
- Acute Myeloid Leukemia Research 5
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 6
-
- Viral-associated cancers and disorders 8
-
- Radiomics and Machine Learning in Medical Imaging 8
-
- Ubiquitin and proteasome pathways 7
-
- T-cell and Retrovirus Studies 6
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Nucleic Acids Research (1 paper)Nature Communications (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Jingyan Xu
71 papers receiving 832 citations
Peers
Comparison fields: 5 of 97
- Pathology and Forensic Medicine 237
- Hematology 141
- Genetics 102
- Oncology 203
- Physiology 21
Countries citing papers authored by Jingyan Xu
This map shows the geographic impact of Jingyan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingyan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingyan Xu more than expected).
Fields of papers citing papers by Jingyan Xu
This network shows the impact of papers produced by Jingyan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingyan Xu. The network helps show where Jingyan Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jingyan Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 7 | |
| 6 | 2023 | 10 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 11 | |
| 9 | 2021 | 8 | |
| 10 | 2020 | 22 | |
| 11 | 2020 | 11 | |
| 12 | 2019 | 2 | |
| 13 | 2017 | 18 | |
| 14 | 2016 | 16 | |
| 15 | 2015 | 11 | |
| 16 | 2015 | 15 | |
| 17 | 2014 | 18 | |
| 18 | 2013 | 14 | |
| 19 | 2013 | 3 | |
| 20 | 2009 | 14 |
About Jingyan Xu
Jingyan Xu is a scholar working on Hematology, Pathology and Forensic Medicine and Genetics, having authored 79 papers that have together received 845 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (24 papers), Viral-associated cancers and disorders (8 papers), Radiomics and Machine Learning in Medical Imaging (8 papers), Ubiquitin and proteasome pathways (7 papers), T-cell and Retrovirus Studies (6 papers), Chronic Lymphocytic Leukemia Research (6 papers), Multiple Myeloma Research and Treatments (6 papers) and Acute Myeloid Leukemia Research (5 papers). The work is most often cited by research in Pathology and Forensic Medicine (237 citations), Hematology (141 citations) and Genetics (102 citations). Jingyan Xu has collaborated with scholars based in China and United States. Frequent co-authors include Jing Wang, Min Zhou, Jian Ouyang, Bing Chen, Rongfu Zhou, Hui Hui, Qinglong Guo, Po Hu, Xiaoxuan Yu and Qiguo Zhang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.